Bill Miller's position in Bristol-Myers Squibb is currently worth $3.85M. That's 0.99% of their equity portfolio (29th largest holding). Bill Miller started to build up the position in Bristol-Myers Squibb in Q1 2024 and continued to invest until Q4 2024. Since then they sold 38.5k shares. The stake costed the investor $3.57M, netting the investor a gain of 7.9% so far.